What Are the Benefits of N-Acetylcysteine Supplementation?
Physicians use the detoxifying properties of acetylcysteine and glutathione to treat acetaminophen (paracetamol) poisoning. During the breakdown of acetaminophen by cytochrome P450 enzymes in the liver, a toxic metabolite is produced that damages liver cells. This becomes particularly dangerous when recommended daily doses are exceeded and the body's glutathione stores become depleted. Glutathione binds this toxic acetaminophen metabolite and facilitates its elimination through the urine.
When taken orally, acetylcysteine is intended to dissolve thick mucus and relieve coughing. The mucus produced in the bronchi consists largely of polysaccharides that are held together by disulfide bonds. Because acetylcysteine contains a sulfur group through its cysteine component, it can break these existing disulfide bonds. In this way, acetylcysteine is believed to liquefy mucus and promote expectoration. However, scientific evidence supporting this mechanism remains inconclusive. An alternative explanation for its beneficial effects on coughing is its anti-inflammatory activity. Through its sulfur group, acetylcysteine can bind free radicals that would otherwise cause oxidative damage and activate pro-inflammatory transcription factors.
Longevity researchers assume that mitochondrial dysfunction and excessive oxidative stress within cells contribute to premature aging. These factors increase the risk of chronic diseases such as cancer, type 2 diabetes, and atherosclerosis. Glutathione helps maintain the natural balance of reactive oxygen species (ROS) within cells. It contributes to preserving mitochondrial function and reducing the risk of ROS-related diseases.
The bioavailability of conventionally administered oral glutathione is relatively low. Oral acetylcysteine therefore provides an effective strategy for increasing the body's own glutathione stores by supplying its essential precursor, cysteine. Particularly popular—and supported by several randomized clinical trials—is the combination of NAC with glycine, another important building block of glutathione.
When taken orally, acetylcysteine is considered non-toxic. The therapeutic dosage ranges from 0.4 g to 0.6 g per day. According to the European Food Safety Authority (EFSA), exceeding this dosage may cause gastrointestinal discomfort in sensitive individuals. In the past, intravenous administration of acetylcysteine has occasionally resulted in overdosing and serious adverse reactions.
References
Further information and scientific studies on the active ingredient N-acetylcysteine can be found here.
Bioavailability Study of an Innovative Orobuccal Formulation of Glutathione
www.ncbi.nlm.nih.gov/pmc/articles/PMC4663342
Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) on a Request from the Commission Related to N-Acetyl-L-Cysteine for Use in Foods for Particular Nutritional Uses and in Foods for Special Medical Purposes
www.efsa.europa.eu/en/efsajournal/pub/21
Effects of N-Acetylcysteine, Oral Glutathione (GSH), and a Novel Sublingual Form of GSH on Oxidative Stress Markers: A Comparative Crossover Study
www.ncbi.nlm.nih.gov/pmc/articles/PMC4536296
N-Acetylcysteine Mucolysis in the Management of Chronic Obstructive Pulmonary Disease
www.pubmed.ncbi.nlm.nih.gov/22361928
N-Acetylcysteine—A Safe Antidote for Cysteine/Glutathione Deficiency
www.sciencedirect.com/science/article/abs/pii/S1471489207000896
Oxidative Stress and Exceptional Human Longevity: A Systematic Review
www.pubmed.ncbi.nlm.nih.gov/31550529
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Hallmarks of Aging: A Randomized Clinical Trial
www.pubmed.ncbi.nlm.nih.gov/35975308
Oxidative Stress and Low Glutathione in Common Ear, Nose, and Throat Conditions: A Systematic Review
www.pubmed.ncbi.nlm.nih.gov/27622960